Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
| Autor: | Okamoto, Hiroaki, Shibazaki, Nayumi, Yoshimura, Takeshi, Uzawa, Toyonobu, Sugimoto, Toshitsugu |
|---|---|
| Zdroj: | In Osteoporosis and Sarcopenia March 2020 6(1):15-19 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|